First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Shares Gap Down – Should You Sell?

Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBTGet Free Report) gapped down prior to trading on Monday . The stock had previously closed at $273.91, but opened at $265.60. First Trust NYSE Arca Biotechnology Index Fund shares last traded at $264.8590, with a volume of 2,258 shares.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 0.3%

The business has a 50 day simple moving average of $253.06 and a two-hundred day simple moving average of $223.97. The stock has a market cap of $2.94 billion, a price-to-earnings ratio of 21.72 and a beta of 0.66.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

A number of hedge funds have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock worth $29,000 after acquiring an additional 158 shares during the period. AG Campbell Advisory LLC acquired a new position in First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter worth approximately $31,000. Cassaday & Co Wealth Management LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the 1st quarter worth $34,000. Continuum Advisory LLC purchased a new position in First Trust NYSE Arca Biotechnology Index Fund in the 2nd quarter worth about $35,000. Finally, Parallel Advisors LLC increased its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 1,300.0% in the first quarter. Parallel Advisors LLC now owns 182 shares of the company’s stock worth $37,000 after acquiring an additional 169 shares in the last quarter.

About First Trust NYSE Arca Biotechnology Index Fund

(Get Free Report)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

Featured Articles

Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.